Document is current
Any future updates will be listed below
-
Authors
Mancini, Marcio C.
Halpern, Bruno
de Melo, Maria Edna
Kramer, Caroline K.
- License Information
-
More Information
Article History
Received: 1 June 2026
Accepted: 29 July 2026
First Online: 4 August 2026
Declarations
Ethics approval and consent to participate: Not applicable.
Consent for publication: Not applicable.
Competing interests: MCM has been on speakers’ bureaus for Eli-Lilly, Boehringer Ingelheim, Novo Nordisk, Merck, EMS; has received support for attending meetings and/or traveling from Novo Nordisk and Eurofarma; has participated on advisory boards for Novo Nordisk, Eli-Lilly and Aché, Eli-Lilly, Merck, NC Pharma, Brace Pharma, Boehringer Ingelheim. BH has been on a speakers’ bureau for Novo Nordisk, Eli-Lilly, Boehringer Ingelheim, Astra Zeneca, Merck; has received support for attending meetings and/or travel from Novo Nordisk; has participated on advisory boards for Novo Nordisk, Eli-Lilly, Merck, Currax, Abbott Nutrition. MEM has been on speakers’ bureaus for EMS, Novo Nordisk, Merck; has received support for attending meetings and/or traveling from Novo Nordisk and Eurofarma; has participated on advisory boards for Brace Pharma. CKK has received investigator-initiated research grant from Boehringer Ingelheim not related to this work.
